Petrovic V, Ristic M, Milosavljevic B, Djilas M, Markovic M
PLoS One. 2022; 17(10):e0274674.
PMID: 36223392
PMC: 9555667.
DOI: 10.1371/journal.pone.0274674.
Voss F, Kohler T, Meyer T, Abdullah M, van Opzeeland F, Saleh M
Front Immunol. 2018; 9:2405.
PMID: 30405609
PMC: 6202950.
DOI: 10.3389/fimmu.2018.02405.
Githii S, Revathi G, Muigai A, Kariuki S
Afr J Lab Med. 2017; 2(1):45.
PMID: 29043160
PMC: 5637771.
DOI: 10.4102/ajlm.v2i1.45.
Chen A, Mann B, Gao G, Heath R, King J, Maissoneuve J
Clin Vaccine Immunol. 2015; 22(10):1079-89.
PMID: 26245351
PMC: 4580740.
DOI: 10.1128/CVI.00293-15.
Ren D, Almudevar A, E Pichichero M
Hum Vaccin Immunother. 2015; 11(2):489-97.
PMID: 25692218
PMC: 4514345.
DOI: 10.4161/21645515.2014.990861.
Genome-wide identification of genes essential for the survival of Streptococcus pneumoniae in human saliva.
Verhagen L, de Jonge M, Burghout P, Schraa K, Spagnuolo L, Mennens S
PLoS One. 2014; 9(2):e89541.
PMID: 24586856
PMC: 3934895.
DOI: 10.1371/journal.pone.0089541.
Mucosal immunization with recombinant fusion protein DnaJ-ΔA146Ply enhances cross-protective immunity against Streptococcus pneumoniae infection in mice via interleukin 17A.
Liu Y, Wang H, Zhang S, Zeng L, Xu X, Wu K
Infect Immun. 2014; 82(4):1666-75.
PMID: 24491576
PMC: 3993385.
DOI: 10.1128/IAI.01391-13.
A live-attenuated pneumococcal vaccine elicits CD4+ T-cell dependent class switching and provides serotype independent protection against acute otitis media.
Rosch J, Iverson A, Humann J, Mann B, Gao G, Vogel P
EMBO Mol Med. 2014; 6(1):141-54.
PMID: 24408968
PMC: 3936495.
DOI: 10.1002/emmm.201202150.
Novel role for the Streptococcus pneumoniae toxin pneumolysin in the assembly of biofilms.
Shak J, Ludewick H, Howery K, Sakai F, Yi H, Harvey R
mBio. 2013; 4(5):e00655-13.
PMID: 24023386
PMC: 3774193.
DOI: 10.1128/mBio.00655-13.
Expression of Streptococcus pneumoniae Virulence-Related Genes in the Nasopharynx of Healthy Children.
Sakai F, Talekar S, Lanata C, Grijalva C, Klugman K, Vidal J
PLoS One. 2013; 8(6):e67147.
PMID: 23825636
PMC: 3688971.
DOI: 10.1371/journal.pone.0067147.
Serotype-independent pneumococcal vaccines.
Miyaji E, Oliveira M, Carvalho E, Ho P
Cell Mol Life Sci. 2012; 70(18):3303-26.
PMID: 23269437
PMC: 11113425.
DOI: 10.1007/s00018-012-1234-8.
Distinct effects on diversifying selection by two mechanisms of immunity against Streptococcus pneumoniae.
Li Y, Gierahn T, Thompson C, Trzcinski K, Ford C, Croucher N
PLoS Pathog. 2012; 8(11):e1002989.
PMID: 23144610
PMC: 3493470.
DOI: 10.1371/journal.ppat.1002989.
Impaired CD4 T cell memory response to Streptococcus pneumoniae precedes CD4 T cell depletion in HIV-infected Malawian adults.
Glennie S, Sepako E, Mzinza D, Harawa V, Miles D, Jambo K
PLoS One. 2011; 6(9):e25610.
PMID: 21980502
PMC: 3181344.
DOI: 10.1371/journal.pone.0025610.
Exposure of Thomsen-Friedenreich antigen in Streptococcus pneumoniae infection is dependent on pneumococcal neuraminidase A.
Coats M, Murphy T, Paton J, Gray B, Briles D
Microb Pathog. 2011; 50(6):343-9.
PMID: 21377521
PMC: 3088309.
DOI: 10.1016/j.micpath.2011.02.010.
Immune responses to recombinant pneumococcal PsaA antigen delivered by a live attenuated Salmonella vaccine.
Wang S, Li Y, Shi H, Scarpellini G, Torres-Escobar A, Roland K
Infect Immun. 2010; 78(7):3258-71.
PMID: 20479086
PMC: 2897375.
DOI: 10.1128/IAI.00176-10.
Antibody and cell-mediated immunity to Streptococcus pneumoniae: implications for vaccine development.
Malley R
J Mol Med (Berl). 2010; 88(2):135-42.
PMID: 20049411
DOI: 10.1007/s00109-009-0579-4.
Interleukin-17A mediates acquired immunity to pneumococcal colonization.
Lu Y, Gross J, Bogaert D, Finn A, Bagrade L, Zhang Q
PLoS Pathog. 2008; 4(9):e1000159.
PMID: 18802458
PMC: 2528945.
DOI: 10.1371/journal.ppat.1000159.
Development of antibodies to PspA families 1 and 2 in children after exposure to Streptococcus pneumoniae.
Melin M, Hollingshead S, Briles D, Lahdenkari M, Kilpi T, Kayhty H
Clin Vaccine Immunol. 2008; 15(10):1529-35.
PMID: 18753341
PMC: 2565922.
DOI: 10.1128/CVI.00181-08.
Discovery of a novel class of highly conserved vaccine antigens using genomic scale antigenic fingerprinting of pneumococcus with human antibodies.
Giefing C, Meinke A, Hanner M, Henics T, Bui M, Gelbmann D
J Exp Med. 2008; 205(1):117-31.
PMID: 18166586
PMC: 2234372.
DOI: 10.1084/jem.20071168.
Intranasal immunization with the cholera toxin B subunit-pneumococcal surface antigen A fusion protein induces protection against colonization with Streptococcus pneumoniae and has negligible impact on the nasopharyngeal and oral microbiota of mice.
Pimenta F, Miyaji E, Areas A, Oliveira M, de Andrade A, Ho P
Infect Immun. 2006; 74(8):4939-44.
PMID: 16861686
PMC: 1539618.
DOI: 10.1128/IAI.00134-06.